Chronic spontaneous urticaria presents a severe clinical challenge characterized by recurrent pruritic wheals, angioedema, and significant sleep disruption. While modern clinical guidelines recommend second-generation H1-antihistamines as first-line therapy, many patients experience incomplete disease control. Consequently, researchers continue to evaluate complementary interventions, including acupuncture for urticaria, to address underlying systemic immune dysregulation. Emerging scientific evidence reveals that chronic cutaneous eruptions involve complex cellular imbalances rather than isolated histamine release. Specifically, the dynamic balance between pro-inflammatory T helper 17 cells and immunosuppressive regulatory T cells influences persistent mast cell reactivity. Understanding these cellular mechanisms offers practical clinical value for healthcare professionals managing difficult, recalcitrant cases.

Immunological Imbalance in Chronic Spontaneous Urticaria

Chronic spontaneous urticaria stems from intricate interactions between cutaneous innate immune effectors and adaptive lymphocyte populations. Historically, clinicians regarded urticaria predominantly as a type I hypersensitivity event driven by rapid mast cell degranulation. However, modern immunologic investigations demonstrate that chronic autoreactive inflammation involves sustained activation of the T helper 17 pathway. These Th17 lymphocytes secrete inflammatory mediators, including interleukin-17 and interleukin-23, which recruit neutrophils and increase capillary permeability. In contrast, regulatory T cells preserve peripheral immune tolerance and suppress unrestrained tissue inflammation. When regulatory T cells fail to produce adequate immunosuppressive cytokines, systemic autoimmunity thrives unabated.

Furthermore, an elevated Th17/Treg ratio correlates directly with disease severity in patients suffering from chronic urticaria. Dysfunctional immune tolerance allows functional autoantibodies against high-affinity IgE receptors or circulating IgE molecules to persist unchecked. Moreover, systemic inflammatory cascades exacerbate neuropsychological distress, inducing chronic anxiety and fatigue. Therefore, restoring equilibrium across the Th17 and Treg axis represents an essential therapeutic objective. Clinicians increasingly recognize that antihistamines primarily blunt peripheral receptor activation without correcting upstream T-cell dysfunction.

Investigating Acupuncture for Urticaria in a Randomized Trial

To evaluate whether somatic stimulation can alter adaptive immune pathways, a randomized controlled trial assessed acupuncture for urticaria against standard antihistamines. The investigation enrolled eighty adult patients diagnosed with persistent chronic spontaneous urticaria. Researchers randomly assigned the participants into two equal groups of forty patients each. During the eight-week intervention window, four participants discontinued treatment, leaving seventy-six fully evaluable patients across both study arms. The observation group underwent manual acupuncture three times weekly for eight consecutive weeks.

Specifically, licensed acupuncturists stimulated bilateral acupoints, including Jianyu, Shousanli, Quchi, Pianli, Xuehai, Zusanli, and Sanyinjiao. Each treatment session lasted thirty minutes to maintain adequate needle stimulation. Meanwhile, control subjects ingested oral ebastine at standard therapeutic doses of ten milligrams once daily. Investigators systematically recorded subjective clinical scores and objective laboratory parameters before and after the trial. Consequently, the study protocol provided a transparent comparison between somatic neuro-immunomodulation and conventional second-generation H1-receptor blockade.

Clinical Symptom Reduction and Quality of Life Enhancements

The trial demonstrated significant clinical improvements across both treatment arms after eight weeks of therapy. Specifically, participants in both cohorts exhibited sharp reductions in their 7-day urticaria activity scores, reflecting decreased wheal counts and less pruritus. In addition, validated patient-reported surveys showed substantial improvements in Dermatology Life Quality Index scores. Notably, patients receiving manual acupuncture demonstrated marked reductions in psychological distress, achieving significantly lower Hamilton Anxiety Scale scores.

Furthermore, psychological well-being often mirrors dermatologic stabilization, because persistent pruritus severely disrupts nocturnal sleep and emotional stability. Ebastine effectively suppressed peripheral cutaneous flare-ups throughout the intervention period, delivering rapid symptomatic control. However, the acupuncture cohort achieved comparable symptom suppression while showing superior improvements in emotional wellness. Therefore, somatic therapies can attenuate distressing cutaneous signs without inducing pharmacological sedation. These combined results confirm that targeted needle stimulation provides comprehensive physical and psychological relief in chronic urticaria.

Targeted Modulation of the Th17 and Treg Axis

Beyond evaluating clinical symptom scores, investigators conducted detailed laboratory analyses to examine systemic immunomodulatory pathways. Specifically, researchers measured peripheral blood proportions of circulating Th17 cells and Treg cells before and after therapy. Additionally, the investigators quantified circulating serum levels of key cytokines, including IL-17, IL-23, IL-10, and IL-35. The laboratory assays demonstrated that somatic stimulation distinctly altered adaptive immune homeostasis.

Remarkably, the acupuncture protocol significantly lowered circulating Th17 cell percentages and reduced serum concentrations of IL-17 and IL-23. Simultaneously, the intervention increased regulatory T cell proportions and elevated protective anti-inflammatory cytokines, specifically IL-10 and IL-35. Consequently, the calculated Th17/Treg ratio decreased dramatically in the acupuncture cohort compared to baseline measurements. While ebastine blocked histamine-mediated vascular reactions, it produced minimal modulation of these deeper cytokine networks. Thus, somatic intervention corrected the fundamental immunological disequilibrium underlying chronic spontaneous urticaria.

Integrating Somatic Interventions into Clinical Practice

These clinical findings carry meaningful implications for dermatologists and integrative healthcare practitioners worldwide. Chronic spontaneous urticaria frequently challenges clinicians when patients demonstrate incomplete responses despite stepped-up antihistamine regimens. Although biological therapies provide targeted relief, substantial financial costs restrict their access across many healthcare environments. Therefore, low-cost non-pharmacological interventions that restore immune tolerance offer valuable adjunctive choices for patient care.

Moreover, acupuncture maintains an excellent safety record when performed by trained practitioners using sterile filiform needles. Because the treatment simultaneously reduces anxiety, it interrupts the bidirectional neuroimmune cycle linking stress with mast cell degranulation. Clinicians should interpret these findings within an evidence-based framework, ensuring that acupoint selection follows standardized clinical protocols. Moving forward, collaborative clinical trials should evaluate combination approaches pairing second-generation antihistamines with adjuvant somatic therapies. Such integrative strategies may optimize long-term remission while reducing pharmacological dependency.

Future Research Directions and Mechanistic Insights

Although these trial results offer compelling insights, future studies must resolve several methodological questions. First, researchers must examine whether acupuncture-induced immune modulation persists after treatment discontinuation. Chronic urticaria displays unpredictable relapsing patterns, making prolonged post-treatment follow-up essential for verifying durable remission. Additionally, larger multicenter trials involving diverse populations remain necessary to confirm these immunological shifts across broad demographic cohorts.

Furthermore, translational studies should clarify the exact neuroimmune pathways connecting peripheral acupoints to central cytokine release. Mechanical needle manipulation activates somatic sensory afferents, which subsequently influence autonomic nerve tone and lymphoid organ function. Consequently, identifying these neuroendocrine circuits will explain how peripheral stimulation suppresses Th17 differentiation while promoting Foxp3-positive regulatory cells. As medical science advances, rigorous clinical research will continue bridging traditional somatic therapies with modern cellular immunology.

Frequently Asked Questions

How does acupuncture modulate the immune system in chronic spontaneous urticaria?

Acupuncture modulates cellular immunity by rebalancing the Th17 and regulatory T cell ratio in peripheral blood. Specifically, somatic needle stimulation suppresses pro-inflammatory cytokines such as IL-17 and IL-23, while simultaneously elevating protective cytokines like IL-10 and IL-35. This coordinated immunological shift downregulates chronic vascular inflammation, reduces mast cell reactivity, and restores systemic immune tolerance without inducing pharmaceutical side effects.

Can acupuncture replace standard second-generation antihistamines for urticaria management?

Current clinical evidence does not support replacing first-line antihistamines with acupuncture as an exclusive standalone therapy. Instead, rigorous trials demonstrate that acupuncture serves as an effective complementary modality alongside standard medical treatment. While antihistamines provide rapid blockade of peripheral H1 receptors, acupuncture addresses deeper immune dysregulation and anxiety. Therefore, integrative clinicians recommend combining both modalities to enhance symptom control in difficult, treatment-resistant cases.

Which specific acupuncture points were evaluated in this randomized controlled clinical trial?

The randomized trial utilized seven classic bilateral acupoints: Jianyu, Shousanli, Quchi, Pianli, Xuehai, Zusanli, and Sanyinjiao. Practitioners administered thirty-minute sessions three times per week over eight continuous weeks to achieve sustained therapeutic efficacy. Traditional frameworks associate these points with clearing pathogenic heat and harmonizing blood, while contemporary physiological studies demonstrate their ability to modulate peripheral microcirculation and autonomic neuroimmune signaling pathways.

Disclaimer: This content is for informational and educational purposes only... Refer to the latest local and national guidelines for clinical practice.

References

1. Guo J et al. [Acupuncture regulates the Th17/Treg axis for chronic spontaneous urticaria: a randomized controlled trial]. Zhongguo Zhen Jiu. 2026 Oct 12. doi: 10.13703/j.0255-2930.20260119-k0001. PMID: 42864289.
2. Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al. The international EAACI/GA²LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2022;77(3):734-766. doi:10.1111/all.15090.
3. Wei Y, Dong H, Liu B, et al. Clinical efficacy and safety of acupuncture in the treatment for chronic spontaneous urticaria: a systematic review and meta-analysis. Front Med (Lausanne). 2025;12:1498795. doi:10.3389/fmed.2025.1498795.